Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as
the adjuvant treatment in postmenopausal breast cancer patients.